Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Labelling people as pre-diabetic is drastically premature measure with no medical value

Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota.

15 Jul 2014

Improving type 2 diabetes management: an interview with Sir Michael Hirst, President of the International Diabetes Federation

One study suggested that 42 percent of people with type 2 diabetes who are treated for the disease do not reach their blood sugar goals, putting them at higher risk of organ and tissue damage, blindness and even death. We wanted to explore potential causes of clinical inertia among physicians and people with diabetes, which may lead to sub-optimal care.

14 Jul 2014

Women experiencing stressful events the day before eating high-fat meal can slow body's metabolism

A new study in women suggests that experiencing one or more stressful events the day before eating a single high-fat meal can slow the body's metabolism, potentially contributing to weight gain.

14 Jul 2014

Portable, microchip-based test for diagnosing type-1 diabetes

An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School of Medicine.

14 Jul 2014

Researchers examine lives of diabetic pupils who receive inadequate support from schools

The project entitled 'Young people with diabetes and their peers' led by Dr Brooks - who is a psychologist with the University of Huddersfield's Centre for Applied Psychological and Health Research - set out to examine the lives of young diabetics from the age when they are starting to be more independent, they have now published their research.

11 Jul 2014

$FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL$

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).

7 Jul 2014

Promising new drug for metabolic syndrome

University of Utah researchers have discovered that an enzyme involved in intracellular signaling plays a crucial role in developing metabolic syndrome, a finding that has a U of U spinoff company developing a drug to potentially treat the condition.

4 Jul 2014

Diabetes easier to control with insulin pump than self-injections?

Insulin pump therapy may be an effective alternative for people who cannot control their diabetes effectively using daily self-injections, show study findings.

3 Jul 2014

GNS automated data analytics can predict future risk of metabolic syndrome in patients

Research published today in The American Journal of Managed Care demonstrates that analysis of patient records using state-of-the-art data analytics can predict future risk of metabolic syndrome.

28 Jun 2014

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.

28 Jun 2014

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Sinai Hospital of Baltimore endocrinologist, Henry G. Fein, M.D., today presented new research showing that patients with Cushing's syndrome, a rare disease that can lead to extreme weight gain, type 2 diabetes, high blood pressure and psychological issues, experienced significant, sustained weight loss while taking oral medication daily over a number of years to manage symptoms of the disease.

25 Jun 2014

New study shows that bariatric patients face lower cancer risks

A new study published in the journal Obesity Surgery indicates that bariatric patients benefit from a significantly decreased risk of cancer compared to other obese patients.

25 Jun 2014

RYGB surgery can help reduce heart disease risk in obese patients with Type 2 diabetes

Obese patients with Type 2 diabetes who don't have excessive surgical risk may find that Roux-en-Y gastric bypass (RYGB) surgery can help them reduce their risk of heart disease, a new clinical trial shows.

24 Jun 2014

Gelesis100 capsule leads to greater weight loss in overweight, obese individuals

A new "smart pill" called Gelesis100 safely leads to greater weight loss in overweight and obese individuals compared with those who receive an active comparator/placebo capsule, while all subjects have similar diet and exercise instructions, an international multicenter study finds.

24 Jun 2014

Pilot study to evaluate advanced artificial pancreas technology under real-world situations

For several years, JDRF-funded researchers at the University of Virginia Center for Diabetes Technology have been hard at work designing an artificial pancreas system that would allow individuals with type 1 diabetes (T1D) to go about their daily lives and sleep through the night with less worry about life-threatening blood-sugar highs and lows.

24 Jun 2014

Guide to treating endocrine and metabolic emergencies released at ICE/ENDO 2014

The Endocrine Society's publishing imprint Endocrine Press released its first original title, Endocrine and Metabolic Medical Emergencies, today during the Society's annual meeting, ICE/ENDO 2014.

24 Jun 2014

Mice exposed to fungicide tolyfluanid show metabolic changes

Mice exposed to the fungicide tolyfluanid (TF) showed metabolic changes similar to those that signify the development of the metabolic syndrome. The results, which were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

24 Jun 2014

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.

24 Jun 2014

Adults with Type 2 diabetes achieve better blood glucose control after sleeve gastrectomy surgery

Adults with Type 2 diabetes achieve better blood glucose (sugar) control two years after undergoing laparoscopic sleeve gastrectomy than do patients who receive standard medical diabetes care without this weight loss surgery, a new study finds.

23 Jun 2014

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Soy protein supplements, which contain natural estrogens, do not reduce testosterone levels in men with Type 2 diabetes who already have borderline-low testosterone, according to a new study.

23 Jun 2014

Blood Sugar News and Research

Further Reading

Labelling people as pre-diabetic is drastically premature measure with no medical value

Improving type 2 diabetes management: an interview with Sir Michael Hirst, President of the International Diabetes Federation

Women experiencing stressful events the day before eating high-fat meal can slow body's metabolism

Portable, microchip-based test for diagnosing type-1 diabetes

Researchers examine lives of diabetic pupils who receive inadequate support from schools

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Promising new drug for metabolic syndrome

Diabetes easier to control with insulin pump than self-injections?

GNS automated data analytics can predict future risk of metabolic syndrome in patients

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

New study shows that bariatric patients face lower cancer risks

RYGB surgery can help reduce heart disease risk in obese patients with Type 2 diabetes

Gelesis100 capsule leads to greater weight loss in overweight, obese individuals

Pilot study to evaluate advanced artificial pancreas technology under real-world situations

Guide to treating endocrine and metabolic emergencies released at ICE/ENDO 2014

Mice exposed to fungicide tolyfluanid show metabolic changes

Researchers develop GI microbiome modulators to treat prediabetes and diabetes

Adults with Type 2 diabetes achieve better blood glucose control after sleeve gastrectomy surgery

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News